Total Payments
$517.63
2024 Payments
$22.25
Companies
9
Transactions
20
Medicare Patients
907
Medicare Billing
$65,798
Payment Breakdown by Category
Food & Beverage$517.63 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $517.63 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $273.05 | 11 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $103.68 | 2 | $0 (2019) |
| AbbVie Inc. | $34.67 | 1 | $0 (2023) |
| Novo Nordisk Inc | $22.25 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $20.87 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $19.71 | 1 | $0 (2019) |
| Gilead Sciences Inc | $16.32 | 1 | $0 (2017) |
| Lilly USA, LLC | $13.56 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $13.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.25 | 1 | Novo Nordisk Inc ($22.25) |
| 2023 | $34.67 | 1 | AbbVie Inc. ($34.67) |
| 2020 | $28.85 | 2 | GlaxoSmithKline, LLC. ($28.85) |
| 2019 | $83.62 | 5 | GlaxoSmithKline, LLC. ($31.67) |
| 2018 | $161.77 | 5 | GlaxoSmithKline, LLC. ($140.90) |
| 2017 | $186.47 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($85.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Diabetes | ||||||
| 01/19/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, BEXSERO | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: VACCINES | ||||||
| 02/12/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, BEXSERO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: VACCINES | ||||||
| 10/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: DIABETES | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Respiratory | ||||||
| 06/07/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 03/02/2019 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO, BOOSTRIX | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: VACCINES | ||||||
| 01/09/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, BOOSTRIX | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: VACCINES | ||||||
| 12/13/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, BOOSTRIX | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: VACCINES | ||||||
| 10/03/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, PEDIARIX | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: VACCINES | ||||||
| 07/10/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $82.85 | General |
| Category: VACCINES | ||||||
| 03/29/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, PEDIARIX | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: VACCINES | ||||||
| 02/28/2018 | Otsuka America Pharmaceutical, Inc. | BREATHTEK (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2017 | GlaxoSmithKline, LLC. | MENVEO (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: VACCINES | ||||||
| 08/03/2017 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, FLULAVAL | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: VACCINES | ||||||
| 06/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: DIABETES | ||||||
| 05/12/2017 | GlaxoSmithKline, LLC. | MENVEO (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: VACCINES | ||||||
| 04/06/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $16.32 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 447 | 491 | $126,066 | $29,159 |
| 2022 | 11 | 424 | 503 | $102,693 | $34,857 |
| 2020 | 1 | 36 | 36 | $7,776 | $1,782 |
Total Patients
907
Total Services
1,030
Medicare Billing
$65,798
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $40,680 | $11,440 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 136 | $50,447 | $9,105 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 96 | $25,236 | $4,690 | 18.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $3,729 | $1,782 | 47.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $2,520 | $975.57 | 38.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 62 | $1,042 | $512.40 | 49.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $1,500 | $486.60 | 32.4% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 12 | $912.00 | $166.80 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 150 | $48,900 | $12,939 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $13,632 | $9,779 | 71.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 92 | $19,872 | $6,056 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $13,000 | $2,858 | 22.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $1,596 | $1,565 | 98.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $1,736 | $955.43 | 55.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 15 | $840.00 | $291.90 | 34.8% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $836.00 | $156.27 | 18.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 40 | 41 | $1,886 | $135.65 | 7.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 23 | $230.00 | $78.84 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 15 | $165.00 | $41.46 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 36 | $7,776 | $1,782 | 22.9% |
About Dr. Olha Duda, M.D
Dr. Olha Duda, M.D is a Family Medicine healthcare provider based in Athol, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1740597459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Olha Duda, M.D has received a total of $517.63 in payments from pharmaceutical and medical device companies, with $22.25 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($517.63).
As a Medicare-enrolled provider, Duda has provided services to 907 Medicare beneficiaries, totaling 1,030 services with total Medicare billing of $65,798. Data is available for 3 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Athol, MA
- Active Since 09/02/2010
- Last Updated 01/17/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1740597459
Products in Payments
- BEXSERO (Biological) $164.04
- JARDIANCE (Drug) $103.68
- SHINGRIX (Biological) $48.55
- MENVEO (Biological) $48.49
- QULIPTA (Drug) $34.67
- Rybelsus (Drug) $22.25
- BREATHTEK (Device) $20.87
- SYMBICORT (Drug) $19.71
- TRULICITY (Drug) $13.56
- UTIBRON (Drug) $13.52
- PEDIARIX (Biological) $11.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athol
Jennifer Mark, M.d, M.D
Family Medicine — Payments: $166.41
Family Medicine $166.41
Timothy Soule-Regine, Md, MD
Family Medicine — Payments: $87.52
Family Medicine $87.52
Ashley Warner, Md, MD
Family Medicine — Payments: $80.68
Family Medicine $80.68
Jacquelyn Mckean, Md, MD
Family Medicine — Payments: $46.71
Family Medicine $46.71
Diane Grasso, Np, NP
Family Medicine
Family Medicine